LAG3 and neoplasm: Similarly, significantly elevated percentages of CD8+ T cells expressing LAG-3 (31.50 ± 8.33% of CD8+ T cells), and PD-1 (13.01 ± 3.82% of CD8+ T cells) were detected in tumor tissues (Figure 6A), as well.